Dr. William Frederick Lambert, DPM MD Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 525 Rivergate Parkway, Suite 3, Goodlettsville, TN 37072 Phone: 615-859-7750 Fax: 615-851-9557 |
Dr. John Boyd Jr., DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 824 Wren Rd, Goodlettsville, TN 37072 Phone: 615-220-8788 Fax: 615-220-8688 |
News Archive
Use of the targeted agent pacritinib significantly reduced the symptoms and burden of advanced myelofibrosis in patients, says a Mayo Clinic researcher who co-led PERSIST-1, the worldwide phase III clinical trial that tested the therapy. Specifically, pacritinib substantially reduced severe enlargement of the spleen, a typical feature of advanced myelofibrosis, in more than 20 percent of patients and alleviated debilitating side effects in more than 46 percent.
One little understood paradox in the study of obesity is that overweight people who break down fat at a high rate are less healthy than peers who store their fat more effectively.
A community-based maternal health delivery strategy known as the MOM Project dramatically increased access to maternal health care services for internally displaced woman in eastern Burma, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. Among the findings, the study showed a ten-fold increase in the proportion of women assisted at delivery by workers skilled in providing emergency obstetric care, including preventing and treating hemorrhage, injectable antibiotics and anticonvulsants, and community-based blood transfusion.
Gilead Sciences, Inc. today announced the initiation of a Phase 2 clinical trial evaluating GS-7340 for the treatment of HIV-1 infection in treatment-naïve adults. GS-7340 is a novel prodrug of tenofovir, the active agent in Viread.
One in every 100 elderly people suffers from Parkinson's disease, a disease of the nervous system with symptoms including stiffness and shaking. The standard medication used to treat Parkinson's is Levodopa, a drug that initially has major benefits but can later also produce serious side effects in the form of involuntary, jerky movements. A research group at Lund University has now found a way to study what it is in the brain that causes these side effects.
› Verified 1 days ago